Deep Brain Stimulation Market

  • Published on 2025-11-10
  • Report Code: 822
  • 172 pages
Deep Brain Stimulation Market

Deep Brain Stimulation Market – Share, Revenue & Growth Rate to Increase During Forecast Year 2020-2030” report examines global trends, applications, and revenue-growth dynamics in the neurological neurostimulation sector.

Table Of Content

Contents          

  1. Executive Summary
  2. Global Deep Brain Stimulation Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Deep Brain Stimulation Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Deep Brain Stimulation Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Deep Brain Stimulation Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia, Thailand, Malaysia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Latin America: (Brazil, Mexico, Argentina, Colombia, Chile and Venezuela), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. MEA: (South Africa, Saudi Arabia, UAE, Turkey and Iran), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Stimulation Type: Market Share (2020-2030F)
      1. Subthalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Globus Pallidus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Thalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Pedunculopontine Nucleus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Product: Market Share (2020-2030F)
      1. Single Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Dual Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Application: Market Share (2020-2030F)
      1. Parkinson's Disease (PD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Epilepsy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Dystonia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Obsessive Compulsive Disorder (OCD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    5. By End-User: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Ambulatory Surgical Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Neurological Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Medtronic
  3. Boston Scientific Corporation
  4. Aleva Neurotherapeutics S.A.
  5. Nexstim
  6. LivaNova PLC
  7. Neuropace Inc.
  8. Renishaw PLC
  9. Beijing PINS Medical Co. Ltd
  10. Fisher Wallace

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients